[Antiviral prophylaxis for CMV, HSV/VZV and HBV in allogeneic hematopoietic cell transplantation in adult patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]

Bull Cancer. 2020 Jan;107(1S):S1-S6. doi: 10.1016/j.bulcan.2019.09.002. Epub 2019 Oct 15.
[Article in French]

Abstract

The Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organizes annual workshops in the attempt to harmonize clinical practices among different francophone transplantation centers. Here, we report our recommendations regarding the prophylaxis of cytomegalovirus (CMV), herpes simplex virus (HSV), varicella zoster virus (VZV) and hepatitis B virus infection after allogeneic hematopoietic cell transplantation in adult patients.

Keywords: Allogeneic stem cell transplantation; Allogreffe de cellules souches hématopoïétiques; CMV; HBV; HSV; HVS; Prophylaxie; Prophylaxis; VHB; VZV.

Publication types

  • Consensus Development Conference
  • Practice Guideline
  • Review

MeSH terms

  • Acetates / administration & dosage
  • Acetates / therapeutic use
  • Adult
  • Allografts
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / therapeutic use*
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / prevention & control*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hepatitis B / drug therapy
  • Hepatitis B / prevention & control*
  • Herpes Simplex / drug therapy
  • Herpes Simplex / prevention & control*
  • Herpes Zoster / drug therapy
  • Herpes Zoster / prevention & control*
  • Humans
  • Quinazolines / administration & dosage
  • Quinazolines / therapeutic use
  • Transplantation Conditioning / adverse effects*

Substances

  • Acetates
  • Antiviral Agents
  • Quinazolines
  • letermovir